Cronus Pharma Specialities India Profile
Key Indicators
- Authorised Capital ₹ 190.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 119.11 Cr
as on 17-11-2024
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 148.30 Cr
as on 17-11-2024
- Revenue 83.83%
(FY 2023)
- Profit 153.77%
(FY 2023)
- Ebitda 183.84%
(FY 2023)
- Net Worth 159.38%
(FY 2023)
- Total Assets 7.86%
(FY 2023)
About Cronus Pharma Specialities India
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 190.00 Cr and a paid-up capital of Rs 119.11 Cr.
The company currently has active open charges totaling ₹148.30 Cr.
The Key Managerial Personnel (KMP) at Cronus Pharma Specialities India Private Limited India is Srividya Rapalli as COMPANY SECRETARY. Kavuru Kumar, Muralikrishna Vallabhaneni, and Mallemputi Chowdary serve as directors at the Company.
- CIN/LLPIN
U24232TG2015PTC100543
- Company No.
100543
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Cronus Pharma Specialities India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srividya Rapalli  | Company Secretary | 01-Jun-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mallemputi Chowdary | Director | 02-Sep-2015 | Current |
| Kavuru Kumar | Director | 02-Sep-2015 | Current |
| Muralikrishna Vallabhaneni | Director | 26-Feb-2024 | Current |
Financial Performance and Corporate Structure Insights of Cronus Pharma Specialities India.
Cronus Pharma Specialities India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 83.83% increase. The company also saw a substantial improvement in profitability, with a 153.77% increase in profit. The company's net worth Soared by an impressive increase of 159.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cronus Pharma Specialities India?
In 2023, Cronus Pharma Specialities India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cronus Research Labs Private LimitedActive 10 years 1 monthKavuru Kumar and Mallemputi Chowdary are mutual person
- Gensource Pharma Solutions Private LimitedActive 14 years 9 months
Kavuru Kumar and Mallemputi Chowdary are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Oct 2018 | ₹148.30 Cr | Open |
How Many Employees Work at Cronus Pharma Specialities India?
Cronus Pharma Specialities India has a workforce of 272 employees as of May 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cronus Pharma Specialities India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cronus Pharma Specialities India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
